Rebecca E. O’Connor
Pfizer (United States)(US)University of Kent(GB)
Publications by Year
Research Areas
Chromosomal and Genetic Variations, Genetic diversity and population structure, Genomics and Phylogenetic Studies, Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities, Genetic Mapping and Diversity in Plants and Animals
Most-Cited Works
- → An improved pig reference genome sequence to enable pig genetics and genomics research(2020)437 cited
- → Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19(2021)288 cited
- → Discovery of a Novel Class of Phosphodiesterase 10A Inhibitors and Identification of Clinical Candidate 2-[4-(1-Methyl-4-pyridin-4-yl-1 H -pyrazol-3-yl)-phenoxymethyl]-quinoline (PF-2545920) for the Treatment of Schizophrenia†Coordinates of the PDE10A crystal structures have been deposited in the Protein Data Bank for compound 1 (3HQW), 2 (3HQY), 3 (3HQW) and 9 (3HR1).(2009)201 cited
- → Discovery of a Novel Inhibitor of Coronavirus 3CL Protease for the Potential Treatment of COVID-19(2020)159 cited
- → A Comparative Analysis of SARS-CoV-2 Antivirals Characterizes 3CL pro Inhibitor PF-00835231 as a Potential New Treatment for COVID-19(2021)140 cited
- → Upgrading short-read animal genome assemblies to chromosome level using comparative genomics and a universal probe set